(Q35813629)

10 August 2017

1 reference

title

Endothelial dysfunction, inflammation and diabetes (English)

1 reference

10 August 2017

0 references

Paresh Dandona

1 reference

10 August 2017

Ahmad Aljada

series ordinal

1 reference

10 August 2017

Ajay Chaudhuri

series ordinal

1 reference

10 August 2017

Priya Mohanty

series ordinal

1 reference

10 August 2017

publication date

1 August 2004

1 reference

Reviews in Endocrine and Metabolic Disorders

10 August 2017

published in

1 reference

10 August 2017

1 reference

10 August 2017

1 reference

10 August 2017

page(s)

189-197

1 reference

Angiotensin II receptor blocker valsartan suppresses reactive oxygen species generation in leukocytes, nuclear factor-kappa B, in mononuclear cells of normal subjects: evidence of an antiinflammatory action

10 August 2017

cites work

1 reference

12 December 2020

Mechanisms and consequences of phagocyte adhesion to endothelium

1 reference

12 December 2020

Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes

1 reference

12 December 2020

Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance

1 reference

12 December 2020

Prostacyclin effects on adenylate cyclase in platelets and vascular smooth muscle: interaction with an inhibitory receptor or partial agonism?

1 reference

12 December 2020

Tumor necrosis factor-alpha in sera of obese patients: fall with weight loss

1 reference

12 December 2020

Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events

1 reference

12 December 2020

Influence of insulin and of insulin resistance on platelet and vascular smooth muscle cell function

1 reference

12 December 2020

Carvedilol inhibits reactive oxygen species generation by leukocytes and oxidative damage to amino acids

1 reference

12 December 2020

C-Reactive Protein Is Independently Associated With Fasting Insulin in Nondiabetic Women

1 reference

12 December 2020

Pathways linking depression, adiposity, and inflammatory markers in healthy young adults

1 reference

12 December 2020

Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect?

1 reference

12 December 2020

Fibrinogen, other putative markers of inflammation, and weight gain in middle-aged adults--the ARIC study. Atherosclerosis Risk in Communities

1 reference

12 December 2020

Tumor necrosis factor-alpha inhibits insulin-induced increase in endothelial nitric oxide synthase and reduces insulin receptor content and phosphorylation in human aortic endothelial cells

1 reference

12 December 2020

Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study

1 reference

12 December 2020

Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes

1 reference

12 December 2020

Interleukin-6 induces cellular insulin resistance in hepatocytes

1 reference

12 December 2020

Anti-inflammatory and profibrinolytic effect of insulin in acute ST-segment-elevation myocardial infarction

1 reference

12 December 2020

Impaired glucose tolerance, diabetes, and cardiovascular disease risk factor profiles in the elderly. The Honolulu Heart Program

1 reference

12 December 2020

The generation of TXA2 in human platelet rich plasma and its inhibition by nictindole and prostacyclin

1 reference

12 December 2020

Inflammation-sensitive plasma proteins are associated with future weight gain

1 reference

12 December 2020

Subcutaneous Adipose Tissue Releases Interleukin-6, But Not Tumor Necrosis Factor-α,in Vivo1

1 reference

12 December 2020

Cerebral blood flow in diabetes mellitus: evidence of abnormal cerebrovascular reactivity.

1 reference

12 December 2020

Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes

1 reference

12 December 2020

Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques

1 reference

12 December 2020

Inhibitory mechanism of the protein C pathway on tissue factor-induced thrombin generation. Synergistic effect in combination with tissue factor pathway inhibitor

1 reference

12 December 2020

Nitric oxide and platelet aggregation

1 reference

12 December 2020

Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial

1 reference

12 December 2020

Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus.

1 reference

12 December 2020

Inhibition of platelet-derived mitogen release by nitric oxide (EDRF).

1 reference

12 December 2020

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

Nadolol inhibits reactive oxygen species generation by leukocytes and linoleic acid oxidation

1 reference

12 December 2020

Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes.

1 reference

12 December 2020

Role of endothelium in thrombosis and hemostasis

1 reference

12 December 2020

Functional heterogeneity of vascular endothelial cells

1 reference

12 December 2020

Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women

1 reference

12 December 2020

Tissue oxygenation and skin blood flow in the diabetic foot: responses to cutaneous warming.

1 reference

12 December 2020

Muscle blood flow in diabetes mellitus. Evidence of abnormality after exercise

1 reference

12 December 2020

Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study

1 reference

12 December 2020

Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha

1 reference

12 December 2020

The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

1 reference

12 December 2020

alpha-Glucosidase inhibition in obesity.

1 reference

12 December 2020

Leptin Concentrations in Relation to Body Mass Index and the Tumor Necrosis Factor-α System in Humans1

1 reference

12 December 2020

Insulin inhibits the pro-inflammatory transcription factor early growth response gene-1 (Egr)-1 expression in mononuclear cells (MNC) and reduces plasma tissue factor (TF) and plasminogen activator inhibitor-1 (PAI-1) concentrations

1 reference

12 December 2020

Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients

1 reference

12 December 2020

Elevated serum sialic acid concentration in NIDDM and its relationship to blood pressure and retinopathy

1 reference

12 December 2020

Prostacyclin-sensitive adenylate cyclase and prostacyclin binding sites in platelets and smooth muscle cells

1 reference

12 December 2020

Promoter polymorphisms of the TNF-alpha (G-308A) and IL-6 (C-174G) genes predict the conversion from impaired glucose tolerance to type 2 diabetes: the Finnish Diabetes Prevention Study

1 reference

12 December 2020

C-reactive-protein-associated increase in myocardial infarct size after ischemia/reperfusion

1 reference

12 December 2020

Endothelial control of the cardiovascular system: recent advances

1 reference

12 December 2020

Nuclear factor-kappaB suppressive and inhibitor-kappaB stimulatory effects of troglitazone in obese patients with type 2 diabetes: evidence of an antiinflammatory action?

1 reference

12 December 2020

NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X

1 reference

12 December 2020

Atherosclerosis — An Inflammatory Disease

1 reference

12 December 2020

Increased cutaneous blood flow but impaired post-ischemic response of nutritional flow in obese children

1 reference

12 December 2020

Connecting the role of C-reactive protein and statins in cardiovascular disease

1 reference

12 December 2020

Angiotensin II type 1 receptor antagonist decreases plasma levels of tumor necrosis factor alpha, interleukin-6 and soluble adhesion molecules in patients with chronic heart failure

1 reference

12 December 2020

Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress

1 reference

12 December 2020

Balancing susceptibility to infection and autoimmunity: a role for leptin?

1 reference

12 December 2020

Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk

1 reference

12 December 2020

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

1 reference

12 December 2020

Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study

1 reference

12 December 2020

Accumulation of Type 1 Plasminogen Activator Inhibitor and Vitronectin at Sites of Cellular Necrosis and Inflammation

1 reference

12 December 2020

Suppression of nuclear factor-kappaB and stimulation of inhibitor kappaB by troglitazone: evidence for an anti-inflammatory effect and a potential antiatherosclerotic effect in the obese

1 reference

12 December 2020

Cellular and molecular mechanisms of endothelial cell dysfunction

1 reference

12 December 2020

Inhibition of disaccharide digestion in rat intestine by the alpha-glucosidase inhibitor acarbose (BAY g 5421)

1 reference

12 December 2020

C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

1 reference

12 December 2020

Chronic stress and age-related increases in the proinflammatory cytokine IL-6

1 reference

12 December 2020

Coagulation and fibrinolytic system impairment in insulin dependent diabetes mellitus

1 reference

12 December 2020

How stress influences the immune response

1 reference

12 December 2020

Elaboration of type-1 plasminogen activator inhibitor from adipocytes. A potential pathogenetic link between obesity and cardiovascular disease

1 reference

12 December 2020

The suppressive effect of dietary restriction and weight loss in the obese on the generation of reactive oxygen species by leukocytes, lipid peroxidation, and protein carbonylation

1 reference

12 December 2020

Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus

1 reference

12 December 2020

Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity

1 reference

12 December 2020

Abnormal cerebrovascular carbon dioxide reactivity in people with diabetes

1 reference

12 December 2020

Insulin suppresses plasma concentration of vascular endothelial growth factor and matrix metalloproteinase-9.

1 reference

12 December 2020

The anti-inflammatory and potential anti-atherogenic effect of insulin: a new paradigm

1 reference

12 December 2020

Novel interactions of adiponectin with the endocrine system and inflammatory parameters

1 reference

12 December 2020

Effects of an engineered human anti-TNF-alpha antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM.

1 reference

12 December 2020

The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study

1 reference

12 December 2020

The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase

1 reference

12 December 2020

Stress and diabetes mellitus

1 reference

12 December 2020

Beta-blocker therapy for secondary prevention of myocardial infarction in elderly diabetic patients. Results from the National Cooperative Cardiovascular Project

1 reference

12 December 2020

Significance of acute-phase inflammatory reactants as an indicator of prognosis after acute myocardial infarction: which is the most useful predictor?

1 reference

12 December 2020

10.1023/B:REMD.0000032407.88070.0A

Identifiers

DOI

1 reference

Dimensions Publication ID

10 August 2017

1012050776

0 references

1 reference